887405-34-7 Usage
Description
(4-ISOPROPYL-[1,2,3]TRIAZOL-1-YL)-ACETIC ACID is a chemical compound synthesized and studied for its potential biological and pharmaceutical applications. It is a derivative of triazole, known for its diverse pharmacological activities. The presence of an isopropyl group and acetic acid moiety in this compound suggests its potential as a versatile building block for the synthesis of various pharmacologically active molecules. The triazole ring in the compound also offers potential for metal coordination and bioconjugation applications.
Uses
Used in Pharmaceutical Applications:
(4-ISOPROPYL-[1,2,3]TRIAZOL-1-YL)-ACETIC ACID is used as a building block for the synthesis of various pharmacologically active molecules due to its unique structure and functional groups.
Used in Metal Coordination:
(4-ISOPROPYL-[1,2,3]TRIAZOL-1-YL)-ACETIC ACID is used as a potential candidate for metal coordination applications, which can be useful in various chemical and biological processes.
Used in Bioconjugation:
(4-ISOPROPYL-[1,2,3]TRIAZOL-1-YL)-ACETIC ACID is used for bioconjugation applications, which can be beneficial in the development of new therapeutic agents or chemical tools for studying biological processes.
Used in Research and Development:
(4-ISOPROPYL-[1,2,3]TRIAZOL-1-YL)-ACETIC ACID is used as a subject of research and development, which may lead to the discovery of new therapeutic agents or chemical tools for studying biological processes.
Check Digit Verification of cas no
The CAS Registry Mumber 887405-34-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,8,7,4,0 and 5 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 887405-34:
(8*8)+(7*8)+(6*7)+(5*4)+(4*0)+(3*5)+(2*3)+(1*4)=207
207 % 10 = 7
So 887405-34-7 is a valid CAS Registry Number.
887405-34-7Relevant articles and documents
C5-ANILINOQUINAZOLINE COMPOUNDS AND THEIR USE IN TREATING CANCER
-
Paragraph 0241; 0377, (2018/11/21)
The invention concerns compounds of Formula (I): or pharmaceutically acceptable salts thereof, wherein R1, R2, R3 and R4 have any of the meanings hereinbefore defined in the description; process for their prepar
PHENOXYQUINAZOLINE COMPOUNDS AND THEIR USE IN TREATING CANCER
-
Page/Page column 27; 31; 32, (2018/11/22)
The invention concerns compounds of Formula (I): or pharmaceutically acceptable salts thereof, wherein R1, R2, R3 and R4 have any of the meanings hereinbefore defined in the description; process for their prepar
